"Invokana- The first therapy in 20 years to treat diabetic nephropathy (i.e. DKD) in patients with T2D and albuminuria >300 mg/day"
Dr. David Huffman, MD, MS
Add on dinner meeting, topic is new indication for Invokana.
**Official Board Meeting will be at 6pm, immediately prior to the dinner meeting**
How to cancel after you've registered to attend:
If you can no longer attend after you've registered, then log back into CANAP website, click on the event and then click the link "I can no longer attend." If you have any difficulties cancelling this way, then email both the Education Co-chairs Kelly Licht: Kellylicht@yahoo.com and Noelle Murphy: Nmurphy@southern.edu
Thank you!! - Kelly Licht 11/29/2019